This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Oximesa’s Esteve Teijin deal gets conditional approval in Spain

( February 5, 2026, 14:20 GMT | Official Statement) -- MLex Summary: Oximesa, a provider of home respiratory services, has won Spanish competition approval for its plan to acquire sole control over rival Esteve Teijin Healthcare. To win clearance, Oximesa agreed to invest the cost savings resulting from the deal in measures to boost the company's quality levels for care and innovation. The buyer will also limit price increases for therapy services to the inflation rate for three years.Statement follows. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login